FI925787A7 - Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita - Google Patents

Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita Download PDF

Info

Publication number
FI925787A7
FI925787A7 FI925787A FI925787A FI925787A7 FI 925787 A7 FI925787 A7 FI 925787A7 FI 925787 A FI925787 A FI 925787A FI 925787 A FI925787 A FI 925787A FI 925787 A7 FI925787 A7 FI 925787A7
Authority
FI
Finland
Prior art keywords
proteolytic enzymes
saccharin derivative
derivative inhibitors
inhibitors
saccharin
Prior art date
Application number
FI925787A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI925787A0 (fi
FI925787L (fi
Inventor
Albert Joseph Mura
Dennis John Hlasta
James Howard Ackerman
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of FI925787A0 publication Critical patent/FI925787A0/fi
Publication of FI925787L publication Critical patent/FI925787L/fi
Publication of FI925787A7 publication Critical patent/FI925787A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Fertilizers (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Medicinal Preparation (AREA)
FI925787A 1991-12-19 1992-12-18 Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita FI925787A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81026591A 1991-12-19 1991-12-19

Publications (3)

Publication Number Publication Date
FI925787A0 FI925787A0 (fi) 1992-12-18
FI925787L FI925787L (fi) 1993-06-20
FI925787A7 true FI925787A7 (fi) 1993-06-20

Family

ID=25203432

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925787A FI925787A7 (fi) 1991-12-19 1992-12-18 Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita

Country Status (19)

Country Link
EP (1) EP0547708B1 (Sortimente)
JP (1) JP3179600B2 (Sortimente)
KR (2) KR100292995B1 (Sortimente)
AT (1) ATE233250T1 (Sortimente)
AU (1) AU668694B2 (Sortimente)
CA (1) CA2084857A1 (Sortimente)
CZ (1) CZ283257B6 (Sortimente)
DE (1) DE69232929D1 (Sortimente)
FI (1) FI925787A7 (Sortimente)
HU (1) HU219950B (Sortimente)
IL (1) IL104154A (Sortimente)
MX (1) MX9207449A (Sortimente)
MY (1) MY110104A (Sortimente)
NO (1) NO300770B1 (Sortimente)
NZ (1) NZ245518A (Sortimente)
RU (1) RU2107685C1 (Sortimente)
SG (1) SG52659A1 (Sortimente)
SK (1) SK278390B6 (Sortimente)
TW (1) TW225532B (Sortimente)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5512576A (en) * 1994-12-02 1996-04-30 Sterling Winthrop Inc. 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5541168A (en) * 1994-12-02 1996-07-30 Sterling Winthrop Inc. Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
DE19533643A1 (de) * 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue cyclische Derivate von Benzolsulfonamiden
US5750550A (en) * 1995-09-15 1998-05-12 Sanofi 2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
JP5082033B2 (ja) 2001-12-21 2012-11-28 エグゼリクシス パテント カンパニー エルエルシー Lxrのモジュレーター
DE60330126D1 (de) 2002-02-14 2009-12-31 Pharmacia Corp Substituierte pyridinone als modulatoren für p38 map kinase
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
WO2008040057A1 (en) * 2006-10-04 2008-04-10 Bionomics Limited Novel benzofuran potassium channel blockers and uses thereof
AU2007334323B2 (en) 2006-12-18 2011-03-10 Amgen Inc. Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
AU2007334321B2 (en) 2006-12-18 2012-03-08 Amgen Inc. Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
ES2446418T3 (es) 2007-04-18 2014-03-07 Amgen, Inc Derivados de indanona que inhiben la prolil hidroxilasa
JP2010524942A (ja) 2007-04-18 2010-07-22 アムジエン・インコーポレーテツド プロリルヒドロキシラーゼを阻害するキノロン及びアザキノロン
ES2389063T3 (es) 2007-05-04 2012-10-22 Amgen, Inc Derivados de tienopiridina y tiazolopiridina que inhiben la actividad prolil hidroxilasa
CA2685219C (en) 2007-05-04 2012-06-19 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
EP2203439B1 (en) 2007-09-14 2011-01-26 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
EP2373649B1 (en) 2008-11-28 2013-01-23 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
WO2010130424A1 (en) 2009-05-12 2010-11-18 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
MX386697B (es) 2014-01-21 2025-03-19 Janssen Pharmaceutica Nv Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
KR20200036063A (ko) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
NZ233521A (en) * 1989-05-04 1992-05-26 Sterling Drug Inc 2-substituted saccharin derivatives, preparation and pharmaceutical compositions thereof
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW282463B (Sortimente) * 1991-11-15 1996-08-01 Sterling Winthrop Inc

Also Published As

Publication number Publication date
NO300770B1 (no) 1997-07-21
MX9207449A (es) 1994-03-31
NO924915D0 (no) 1992-12-18
SK374692A3 (en) 1997-02-05
TW225532B (Sortimente) 1994-06-21
JP3179600B2 (ja) 2001-06-25
AU668694B2 (en) 1996-05-16
RU2107685C1 (ru) 1998-03-27
EP0547708B1 (en) 2003-02-26
EP0547708A1 (en) 1993-06-23
IL104154A0 (en) 1993-05-13
JPH05345771A (ja) 1993-12-27
NO924915L (no) 1993-06-21
CA2084857A1 (en) 1993-06-20
FI925787A0 (fi) 1992-12-18
HUT67039A (en) 1995-01-30
AU2829292A (en) 1993-07-08
CZ283257B6 (cs) 1998-02-18
CZ374692A3 (en) 1993-08-11
SG52659A1 (en) 1998-09-28
KR100378968B1 (ko) 2003-04-08
MY110104A (en) 1998-01-27
DE69232929D1 (de) 2003-04-03
ATE233250T1 (de) 2003-03-15
FI925787L (fi) 1993-06-20
KR100292995B1 (ko) 2001-09-17
SK278390B6 (en) 1997-02-05
IL104154A (en) 1996-09-12
NZ245518A (en) 1995-06-27
HU219950B (hu) 2001-09-28
HU9204029D0 (en) 1993-04-28

Similar Documents

Publication Publication Date Title
FI925787A7 (fi) Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita
FI942423A7 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
FI925167A7 (fi) 2-substituoituja sakkariinijohdannaisia, jotka ovat proteolyyttisten entsyymien inhibiittoreita
NO932620D0 (no) Amindiol-proteaseinhibitorer
DE69226820D1 (de) Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen
FI913788A7 (fi) Seriiniproteaasien inhibiittoreita
MC2313A1 (fr) Inhibiteurs d'enzymes
FI20085256L (fi) Retrovirusperäisten proteaasi-inhibiittoreiden yhdistelmä
DK70491D0 (da) Heterocyklisk renininhibitorer
FI962315L (fi) Entsyymi-inhibiittorit
DK674387D0 (da) Proteaseinhibitorer
FI941766A7 (fi) sPLA2:n 1H-indoli-3-etikkahappohydratsidi-inhibiittoreita
FI20012317L (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia hydroksietyyliaminosulfoniamideja
FI950651L (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia sulfonyylialkanoyyliaminohydroksietyyliaminosulfoniamideja
FI950841L (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia N-(alkanoyyliamino-2-hydroksipropyyli)-sulfoniamideja
FI943234A0 (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
FI942625L (fi) Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina
FI971784A0 (fi) Apolipoproteiini B-synteesin estäjiä
EE04241B1 (et) Apolipoproteiin-B sünteesi inhibiitorid
MX9100998A (es) Novedosos inhibidores de escualen sintetasa
FI895962A7 (fi) Proteaasi-inhibiittorit
DK349586A (da) Enzyminhibitor
FI925166A7 (fi) Protedyyttisiä entsyymejä inhiboivia sakkariinijohdannaisia
FI962235L (fi) Uudet bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina
FI896238A7 (fi) Reniini-inhibiittoreita

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SANOFI